Simon Ghaly
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: March 12, 2026
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: September 05, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era.
Journal: Inflammatory bowel diseases
Published: May 23, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease.
Journal: The American journal of gastroenterology
Published: May 19, 2025
Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease.
Journal: Crohn's & colitis 360
Published: March 06, 2025
Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitis.
Journal: Nature communications
Published: January 17, 2025
Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis.
Journal: Nutrients
Published: November 18, 2024
Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.
Journal: Journal of gastroenterology and hepatology
Published: October 25, 2024
Duodenal obstruction secondary to metastatic breast cancer.
Journal: Journal of cancer research and therapeutics
Published: October 22, 2024
Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas.
Journal: Internal medicine journal
Published: June 12, 2024
Last Updated: 09/26/2026